News

Filter

Current filters:

Solaraze

1 to 9 of 50 results

Spain’s Almirall posts solid performance in 2009, setting basis for sustainable long-term growth

01-03-2010

Spain’s leading drugmaker Almirall reported full-year 2009 net sales of 925.5 million euros ($1.25…

AlmirallDiclofenac SodiumEuropeFinancialPharmaceuticalSolarazeVoltaren

Javelin signs $71M deal on Dyloject

26-01-2009

Javelin Pharmaceuticals of the USA has entered into an exclusive European marketing partnership for Dyloject…

Amino AcidsDiclofenac SodiumInjectionPhysostigmine SalicylateSolarazeVoltaren

Abraxis pays initial $15M for Shimoda

14-04-2008

Abraxis BioScience, a fully-integrated US biotechnology company, has completed the acquisition of Shimoda…

AbraxisAmino AcidsDiclofenac SodiumInjectionNystatinOralPhysostigmine SalicylateSolarazeVoltaren

Javelin

17-03-2008

The Scottish Medicines Consortium has recommended USA-based drugmaker Javelin Pharmaceuticals' product…

Amino AcidsDiclofenac SodiumInjectionPhysostigmine SalicylateSolarazeVoltaren

Javelin's Dyloject added to UK hospital formulary

24-12-2007

USA-based Javelin Pharmaceuticals announced at its New York analyst and investor day that the UK approval…

Diclofenac SodiumSolarazeVoltaren

Novartis' Voltaren Gel cleared by FDA

29-10-2007

The US Food and Drug Administration has granted approval for Swiss drug major Novartis' Voltaren (diclofenac…

Diclofenac SodiumDiclofenac Sodium GelNovartisNystatinOralSolarazeVoltarenVoltaren Gel

1 to 9 of 50 results

Back to top